Cargando…
Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We Stand?
PURPOSE OF REVIEW: Poor outcomes in the current coronavirus disease 2019 (COVID-19) pandemic have been attributed to superadded bacterial coinfections. The World Health Organization has reported overzealous usage of broad-spectrum antibiotics during this current pandemic raising concerns of increasi...
Autores principales: | Kayarat, Bhavana, Khanna, Puneet, Sarkar, Soumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286404/ https://www.ncbi.nlm.nih.gov/pubmed/34316152 http://dx.doi.org/10.5005/jp-journals-10071-23855 |
Ejemplares similares
-
Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
por: Kayarat, Bhavana, et al.
Publicado: (2021) -
Sepsis Awareness in India from Internet Search Trends: Where Do We Stand?
por: Kundu, Riddhi, et al.
Publicado: (2017) -
Bevacizumab in Glaucoma: Where do We Stand?
por: Khanna, Anjani
Publicado: (2012) -
Huriez syndrome with superadded dermatophyte infection
por: Surana, Trupti, et al.
Publicado: (2016) -
Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021)